ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Thematic Areas : Medical Sciences
Publisher : Annals of Pediatric Cardiology
Source : Annals of Pediatric Cardiology, Volume 3, Number 1, p.31-34 (2010)
Keywords : acetylsalicylic acid, amoxicillin, anticoagulant agent, antivitamin K, bleeding, brain artery aneurysm, Calcification, carbamazepine, carboxylation, chloramphenicol, clinical practice, cotrimoxazole, cytochrome P450, drug alcohol interaction, drug bioavailability, drug contraindication, drug dose increase, drug effect, drug excretion, drug fever, drug formulation, drug half life, drug mechanism, drug metabolism, drug monitoring, endocarditis, evidence based medicine, fluconazole, food drug interaction, fresh frozen plasma, gangrene, Glenn shunt, groups by age, hair loss, heart left ventricle failure, heart valve prosthesis, heparin, human, hypertension, international normalized ratio, kidney failure, liver failure, loading drug dose, maximum plasma concentration, medical literature, metronidazole, mucocutaneous lymph node syndrome, nonsteroid antiinflammatory agent, osteoporosis, Pediatrics, pericardial effusion, phenobarbital, plasma substitute, Pregnancy, procoagulant, prothrombin time, pulmonary hypertension, recommended drug dose, repeated drug dose, review, rifampicin, rivaroxaban, side effect, skin necrosis, stent, steroid, systematic review, thromboembolism, thrombosis prevention, trachea disease, tracheal calcification, venous thromboembolism, vitamin K group, warfarin, ximelagatran
Campus : Kochi
School : School of Medicine
Department : Paediatric Cardiology
Year : 2010
Abstract : Recent advances in the pediatric heart surgery, especially the Fontan procedure, has necessitated an increased use of oral anticoagulants in pediatric cardiac patients. Warfarin is the standard agent used for most pediatric indications, though there are very few randomized control studies in children regarding its use. This review summarizes the current indications and evidence base regarding the use of oral anticoagulants in the pediatric age group.
Cite this Research Publication : S. Jain and Vaidyanathan, B., “Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature”, Annals of Pediatric Cardiology, vol. 3, pp. 31-34, 2010.